Rochester Clinical Research has been at the forefront of COVID-19 vaccine research. We began our first COVID-19 vaccine trial in August 2020. Since then, RCR has taken on over 10 COVID-19 vaccine trials and is now embarking on COVID-19 vaccine booster research.
Rochester Clinical Research conducted clinical trials on 2 out of the 3 currently EUA COVID-19 vaccines.
|Janssen (Johnson & Johnson)||Pfizer|
|500 Rochester volunteers enrolled and dosed at RCR||400 Rochester Volunteers enrolled and dosed at RCR|
Rochester Clinical Research is committed to staying at the forefront of fighting this pandemic and continuing to research ways to mitigate the spread of COVID-19.
RCR currently has COVID-19 vaccine studies as well as COVID-19 vaccine booster studies. Learn more here.